Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CORBF Global Cord Blood	$1.55 -0.6%	$1.01	$0.25 ▼ $1.75	$188.40M	-0.6	95,119 shs	606 shs
DCGO DocGo	$1.72 +7.5%	$1.54	$1.23 ▼ $5.68	$168.23M	0.96	546,667 shs	498,507 shs
NAKA KindlyMD	$10.13 -4.7%	$11.80	$0.65 ▼ $34.77	$3.81B	34.35	689,267 shs	470,851 shs
PIII P3 Health Partners	$7.19 -1.6%	$6.66	$5.80 ▼ $29.19	$51.68M	0.81	13,584 shs	9,063 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CORBF Global Cord Blood	0.00%	+181.82%	+181.82%	+55.00%	-11.43%
DCGO DocGo	0.00%	+6.17%	+18.62%	+28.36%	-52.49%
NAKA KindlyMD	0.00%	-25.90%	-7.06%	+1,012,999,900.00%	+1,012,999,900.00%
PIII P3 Health Partners	0.00%	+6.05%	-1.24%	-1.51%	-72.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CORBF Global Cord Blood	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DCGO DocGo	2.12 of 5 stars	3.3	3.0	0.0	0.0	1.9	0.8	0.6
NAKA KindlyMD	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	2.2541 of 5 stars	3.3	2.0	0.0	0.0	3.3	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CORBF Global Cord Blood	0.00	N/A	N/A	N/A
DCGO DocGo	2.50	Moderate Buy	$3.59	108.72% Upside
NAKA KindlyMD	0.00	N/A	N/A	N/A
PIII P3 Health Partners	2.50	Moderate Buy	$16.25	126.01% Upside

Current Analyst Ratings Breakdown

Latest PIII, DCGO, CORBF, and NAKA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/21/2025	DCGO DocGo	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$1.45 ➝ $1.60

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CORBF Global Cord Blood	$196.12M	0.96	$1.11 per share	1.40	N/A	∞
DCGO DocGo	$616.55M	0.27	$0.42 per share	4.07	$3.09 per share	0.56
NAKA KindlyMD	$2.72M	1,400.77	N/A	N/A	$0.43 per share	23.56
PIII P3 Health Partners	$1.50B	0.03	N/A	N/A	$10.58 per share	0.68

Compare Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CORBF Global Cord Blood	$79.04M	N/A	∞	N/A	N/A	N/A	N/A	N/A
DCGO DocGo	$19.99M	-$0.19	21.50	N/A	-4.20%	-3.26%	-2.24%	11/6/2025 (Estimated)
NAKA KindlyMD	-$3.62M	-$0.86	∞	N/A	-244.00%	-131.09%	-106.04%	N/A
PIII P3 Health Partners	-$135.85M	-$46.01	N/A	N/A	-9.99%	-183.60%	-17.83%	11/11/2025 (Estimated)

Latest PIII, DCGO, CORBF, and NAKA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	PIII P3 Health Partners	-$3.29	-$6.23	-$2.94	-$6.23	$356.52 million	$355.79 million
8/7/2025	Q2 2025	DCGO DocGo	-$0.06	-$0.11	-$0.05	-$0.11	$77.58 million	$80.42 million
8/5/2025	Q2 2025	NAKA KindlyMD	N/A	-$0.34	N/A	-$0.35	N/A	$0.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CORBF Global Cord Blood	N/A	N/A	N/A	N/A	N/A
DCGO DocGo	N/A	N/A	N/A	N/A	N/A
NAKA KindlyMD	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CORBF Global Cord Blood	N/A	N/A	N/A
DCGO DocGo	N/A	2.36	2.36
NAKA KindlyMD	N/A	13.00	13.00
PIII P3 Health Partners	2.29	0.31	0.31

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CORBF Global Cord Blood	N/A
DCGO DocGo	56.44%
NAKA KindlyMD	N/A
PIII P3 Health Partners	7.75%

Insider Ownership

Company	Insider Ownership
CORBF Global Cord Blood	0.50%
DCGO DocGo	3.80%
NAKA KindlyMD	40.79%
PIII P3 Health Partners	17.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CORBF Global Cord Blood	1,200	121.55 million	N/A	Not Optionable
DCGO DocGo	4,407	97.81 million	94.09 million	Optionable
NAKA KindlyMD	N/A	376.12 million	222.70 million	N/A
PIII P3 Health Partners	500	7.19 million	5.91 million	Not Optionable

PIII, DCGO, CORBF, and NAKA Headlines

Recent News About These Companies

What is William Blair's Estimate for PIII FY2026 Earnings?

August 20, 2025 | americanbankingnews.com

P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

August 14, 2025 | zacks.com

P3 Health Partners Announces Second Quarter 2025 Results

August 14, 2025 | businesswire.com

P3 Health Partners (PIII) Expected to Announce Earnings on Thursday

August 13, 2025 | americanbankingnews.com

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

July 31, 2025 | businesswire.com

P3 Health Partners (PIII) Projected to Post Quarterly Earnings on Wednesday

July 30, 2025 | marketbeat.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

July 28, 2025 | globenewswire.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

July 22, 2025 | globenewswire.com

P3 Health Partners Inc. (PIII) - Yahoo Finance

July 2, 2025 | finance.yahoo.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

June 16, 2025 | globenewswire.com

Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now

June 12, 2025 | zacks.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

June 6, 2025 | globenewswire.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

June 3, 2025 | globenewswire.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

May 27, 2025 | globenewswire.com

Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)

May 26, 2025 | zacks.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

May 23, 2025 | globenewswire.com

P3 Health Partners Inc. (NASDAQ:PIII) Q1 2025 Earnings Call Transcript

May 17, 2025 | msn.com

P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For

May 16, 2025 | finance.yahoo.com

P3 Health Partners Inc (PIII) Q1 2025 Earnings Call Highlights: Strategic Adjustments and ...

May 16, 2025 | finance.yahoo.com

P3 Health Partners reaffirms $130M EBITDA improvement plan as operational initiatives accelerate in 2025

May 16, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PIII, DCGO, CORBF, and NAKA Company Descriptions

Global Cord Blood NYSE:CORBF

$1.55 -0.01 (-0.64%)

As of 08/22/2025 09:40 AM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

DocGo NASDAQ:DCGO

$1.72 +0.12 (+7.50%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.72 0.00 (0.00%)

As of 08/22/2025 07:50 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

KindlyMD NASDAQ:NAKA

$10.13 -0.50 (-4.70%)

As of 08/22/2025 04:00 PM Eastern

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.

P3 Health Partners NASDAQ:PIII

$7.19 -0.12 (-1.64%)

Closing price 08/22/2025 03:55 PM Eastern

Extended Trading

$7.56 +0.37 (+5.15%)

As of 08/22/2025 07:16 PM Eastern

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time